Squalene epoxidase (SQLE), a second rate‐limiting enzyme in cholesterol biosynthesis (Chua et al., 2020; Gill et al., 2011), has been reported as a bona fide oncogene in several cancers, including breast (Brown et al., 2016) and liver (Liu et al., 2018). Here, SQLE is linked to cancer.